It takes teamwork to bring new treatments to cancer patients. Scientists, patients, and donors make it possible for us to create lifesaving therapies. Thanks to our community, we continue to fund groundbreaking scientific studies leading to the next great discoveries. We launch clinical trials that give patients new options and hope. And we bring all of us closer to a world free from the fear of cancer. Read more below about the important people behind the progress at the Cancer Research Institute.

Janie Ferling
When Janie, a mother from L.A., learned that a lump in her neck was malignant melanoma, she was determined to do whatever she could to be around as long as possible for her son.
Brenda Berchtold
Breast Cancer
When Brenda, 51, was first diagnosed with triple-negative breast cancer in 1986, her treatment options were limited. But much has changed since then, and Brenda is now receiving immunotherapy.
Judy Gray
Lung Cancer
When Judy, 68, was facing a diagnosis of stage 4 lung cancer, she took a predictably analytic approach to her treatment options and enrolled in a new immunotherapy clinical trial.
Emily Whitehead
At only 6-years-old, Emily faced a life-threatening recurrence of leukemia. Determined to save her life, her parents enrolled her in a clinical trial.
Marguerite Sullivan
Marguerite credits immunotherapy with allowing her to carry on with her normal life while also receiving the best care for her cancer, metastatic melanoma.
Brendan Connors
After successfully finishing a combination of immunotherapies for metastatic melanoma, 32-year-old Brendan seized any opportunity for adventure.
Don H.
Lung Cancer
When computer professional Don, 61, was facing a grim prognosis from chemo-resistant lung cancer, he did what came naturally: he took to Google to research his options and learned about immunotherapy.
Maureen O'Grady
Lung Cancer
In 2010, Maureen participated in a clinical trial of a new immunotherapy drug called nivolumab to treat her stage 4 lung cancer.
Bob Carlson
Lung Cancer
Because chemotherapy for his stage 4 lung cancer was a concern, Bob, 71, enrolled in an immunotherapy clinical trial.
Richard Catlett
Kidney Cancer
For 7 years, Richard endured round after round of treatment for kidney cancer, but it always came back. Then, in 2013, he enrolled in a clinical trial of nivolumab.
Lynn Luckeroth
Lynn is no stranger to cancer, having lost both her mother and her son to the disease. When she herself was diagnosed with melanoma, she looked to immunotherapy.
Gene Ogle
Pancreatic Cancer
When Gene learned he had pancreatic cancer, he was determined to spend more time with his grandchildren by enrolling in cancer immunotherapy clinical trials.
Sue Bohlin
Sue was free from breast cancer after a five-year battle, but she was diagnosed with a new, unrelated cancer two years later: melanoma.
John Yaryan
Prostate Cancer
When John, a 77-year-old Air Force veteran, was diagnosed with stage IV prostate cancer, he enrolled in a clinical trial to test the immunotherapy Yervoy.
Christine Sable
Ovarian Cancer
Ovarian cancer survivor Christine shares her powerful story of hope and perseverance in the face of "the cancer that whispers."
James P. Allison, Ph.D.
The University of Texas at MD Anderson Cancer Center
CRI Scientific Advisory Council director James Allison explains why "taking the brakes off" T cells is a good way to fight cancer.
Jeffrey Chou, M.D., Ph.D.
Fred Hutchinson Cancer Research Center
New studies from this CRI scientist may help to make colorectal cancer more vulnerable to attack by the immune system.
Ian H. Frazer, AC, FRS, FAA
The University of Queensland, Australia
The CRI Clinical Investigator is modest about his contribution to the development of the recently-announced breakthrough cervical cancer vaccine.
Jing-Ping Hsin, Ph.D.
Memorial Sloan Kettering Cancer Center
The CRI Young Philanthropist Fellow's research on gene expression in cancer can impact the way lymphoma is treated.
Carl H. June, M.D.
University of Pennsylvania
Pancreatic cancer patients will be enrolled in a clinical trial of a new immunotherapy that harnesses the immune system’s ability to fight pancreatic cancer.
Hyam I. Levitsky, M.D.
Johns Hopkins University
Dr. Levitsky is in a unique position to facilitate academic-industry partnerships that will advance the development of cancer immunotherapies.
Haihui Lu, Ph.D.
Whitehead Institute for Biomedical Research
As a postdoctoral fellow funded by CRI, Dr. Lu is forging new knowledge on how breast cancer tumors "hijack" macrophages to facilitate cancer metastasis and immune evasion.
Kunle Odunsi, M.D., Ph.D.
Roswell Park Cancer Institute
CRI physician-scientist Kunle Odunsi, M.D., Ph.D., is leading the way in cancer immunotherapy for ovarian cancer.
Oliver M. Pearce, Ph.D.
University of California, San Diego
A CRI postdoctoral fellow is researching the link between red meat, milk, and carcinomas.
Corrie Painter, Ph.D.
University of Massachusetts
Angiosarcoma patient and CRI postdoctoral fellow Dr. Corrie Painter is studying how immune cells in zebrafish can fight against hers and other cancers.
David A. Reardon, M.D.
Dana-Farber Cancer Institute
For glioblastoma, the most dangerous and aggressive form of brain cancer, fewer than 10 percent of patients survive more than 5 years. Dr. Reardon wants to change that.
Antoni Ribas, M.D., Ph.D.
University of California, Los Angeles
Dr. Ribas, of UCLA, discusses his latest immunotherapy clinical trials and how it'll transform cancer treatment.
Robert Schreiber, Ph.D.
Washington University School of Medicine
By redefining our understanding of the relationship between cancer and the immune system, Dr. Robert Schreiber has brought us closer to cures for cancer
Padmanee Sharma, M.D., Ph.D.
The University of Texas at MD Anderson Cancer Center
Dr. Sharma's translational research focuses on learning how to apply immune-based therapeutic strategies to manipulate components of the human immune system to lead to tumor regression.
Ralph Steinman, M.D.
The Rockefeller University
Dr. Steinman discusses his pioneering research on the role of dendritic cells in the immune system's response to cancer.
Jedd D. Wolchok, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center
The leading immunotherapy expert knows better than almost anyone what clinical trials can do for patients.
Matthew Youngman, Ph.D.
Massachusetts Institute of Technology
A CRI postdoctoral fellow is exploring the link between aging and the immune system, and his work could lead to new immunotherapies that boost protection against cancer.
DJ Eric Prydz
The famous DJ donated ticket sales from his concerts to CRI in honor of super-fan James Lillo.
Inlanta Mortgage
Inlanta Mortgage again chose CRI to be the beneficiary at their yearly conference’s raffle.
Tiffany and Sage Berting
7-year-old Sage wanted to honor those who lost their lives to cancer. So she drew pictures to raise funds for cancer research.
Saddened by the actor Alan Rickman's death from pancreatic cancer, a T-shirt company raised $54,000 for CRI from a Harry Potter-themed T-shirt.
Jessica Haze
A popular makeup artist's goal to raise $100,000 in 100 days for CRI.
Tidewater Travel
Because Janet, a travel agent, lost family and friends to cancer, she wanted to create a cruise fundraiser to support a more effective type of cancer treatment for patients.
Nolan and Ileana Beck
In memory of his lifelong friend, Bryce, Nolan and his wife, Ileana, decided to bike across country to raise funds for immunotherapy research.
Sherri Thompson
Sherri doesn't know a single family that hasn't been touched by cancer. So when she learned of CRI's work, she wanted to do something big and held a benefit concert.
Enphase Energy
Inspired by her coworkers battling cancer, Deborah came up with an idea: she would shave her head if her company raised $5,000 for CRI.
James McGary
Professional longboarder James is going the distance: he's longboarding from Seattle to New York City to raise money for CRI.
Emma Saunders
With her family ravaged by cancer, Emma wanted to do something huge to help conquer the disease. She decided to run in the Great Wall of China Marathon as a fundraiser for CRI.
Jacques C. Nordeman
CRI trustee Jacques Nordeman has been steering the course against cancer for more than three decades.
David Courtenay
Having had four brothers battle cancer, David was inspired to make a 800km fundraising trek a journey of a lifetime.
Mary Jo Bramson
Mary Jo and her friends organized fundraisers over the next 10 years for CRI, raising more than $687,000 in total.
Joel Paula
Cyclist Joel Paula biked 4,000 miles to raise money for the Cancer Research Institute, and to prove he could do it.
Penny Bolton
Each year, Penny holds a fashion fundraiser for cancer research by selling bras for a cause.
Mark E. Fischbach aka Markiplier
Since 2013, Markiplier has creatively leveraged his 50.5 million followers across social media through fun events to raise over $500,000 for CRI’s programs and increase awareness for medical research
Keith Landesman, M.D.
Cardiologist Dr. Landesman tragically lost his life to cancer in 2008. To honor his memory, his family hosts their annual golf tournament and silent auction to support cancer research.
MacLean C. Sellars, Ph.D.
Former CRI postdoctoral fellow MacLean ran the 2012 Marine Corps Marathon in memory of his mother and helped raise $3,000 for CRI.
Alexis Feldman
Since 2008, Alexis Feldman has led a group of highly motivated young New York City professionals who are committed to ending cancer deaths.
Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.